Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2016-12-21 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT BREVIN LES PINS (44250), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE LETOURNEUX : revenue, balance sheet and financial ratios
SARL PHARMACIE LETOURNEUX is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT BREVIN LES PINS (44250),
this company of category PME
shows in 2023 a revenue of 4.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE LETOURNEUX (SIREN 824602999)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
4 278 455 €
N/C
N/C
N/C
N/C
N/C
Net income
335 686 €
303 231 €
355 053 €
392 040 €
313 953 €
291 595 €
298 914 €
139 713 €
EBITDA
N/C
N/C
478 322 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
8.3%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SARL PHARMACIE LETOURNEUX generates positive net income of 336 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 140 k€ -> 336 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
335 686 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
114.902%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.034%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
971.004
438.717
268.835
189.592
154.326
128.134
89.407
114.902
Financial autonomy
8.252
16.433
24.615
31.073
34.368
39.036
42.896
39.034
Repayment capacity
None
None
None
None
None
5.149
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
8.291%
None%
None%
Sector positioning
Debt ratio
114.92025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+6 pts over 3 years
In 2025, the debt ratio of SARL PHARMACIE LETOURNEUX (114.90) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.03%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-6 pts over 3 years
In 2025, the financial autonomy of SARL PHARMACIE LETOURNEUX (39.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.15 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SARL PHARMACIE LETOURNEUX (5.15) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 191.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
169.548
200.64
253.723
290.574
238.331
240.427
148.083
191.418
Interest coverage
None
None
None
None
None
2.582
None
None
Sector positioning
Liquidity ratio
191.422025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good-13 pts over 3 years
In 2025, the liquidity ratio of SARL PHARMACIE LETOURNEUX (191.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.58x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of SARL PHARMACIE LETOURNEUX (2.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SARL PHARMACIE LETOURNEUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
421 128 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
33
0
0
Customer payment term (days)
80
74
39
46
72
4
0
0
Supplier payment term (days)
464
624
569
564
446
33
0
0
Positioning of SARL PHARMACIE LETOURNEUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SARL PHARMACIE LETOURNEUX is estimated at
5 332 411 €
(range 3 618 599€ - 8 367 288€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3618k€5332k€8367k€
5 332 411 €Range: 3 618 599€ - 8 367 288€
NAF 5 année 2025
Valuation method used
Net Income Multiple
335 686 €
×
15.9x
=5 332 412 €
Range: 3 618 600€ - 8 367 289€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE LETOURNEUX with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE LETOURNEUX
What is the revenue of SARL PHARMACIE LETOURNEUX ?
The revenue of SARL PHARMACIE LETOURNEUX in 2023 is 4.3 M€.
Is SARL PHARMACIE LETOURNEUX profitable?
Yes, SARL PHARMACIE LETOURNEUX generated a net profit of 336 k€ in 2025.
Where is the headquarters of SARL PHARMACIE LETOURNEUX ?
The headquarters of SARL PHARMACIE LETOURNEUX is located in SAINT BREVIN LES PINS (44250), in the department Loire-Atlantique.
Where to find the tax return of SARL PHARMACIE LETOURNEUX ?
The tax return of SARL PHARMACIE LETOURNEUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE LETOURNEUX operate?
SARL PHARMACIE LETOURNEUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart